Nasdaq · CIK 0001397183
IVDA Iveda Solutions, Inc.
Insider trading from SEC Form 4. Last filing Feb 25, 2026.
In brief
Iveda Solutions, Inc. (IVDA) has 16 SEC Form 4 filings on file from 5 insiders, the latest filed on Feb 25, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
1 Form 144 notice of planned sales is on file, the latest filed Oct 16, 2025.
Last 90 days
Signals
Open-market buys and sells at Iveda Solutions, Inc., scored.
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 16, 2025 | Gillen Robert Director | 20,331 0.70% of outstanding | $42k | Oct 16, 2025 | none |
Transactions
Every row filed, 21 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | David H. Ly Chief Executive Officer | DDisposition to issuer Options (Right to Buy)derivative | +175,000 | $0.00 | $0 | 216,096 | Feb 25, 2026 |
| Dec 29, 2025 | Robert Gillen director | DDisposition to issuer Options (Right to Buy)derivative | +100,000 | $0.00 | $0 | 128,599 | Feb 25, 2026 |
| Dec 29, 2025 | Alejandro Franco director | DDisposition to issuer Options (Right to Buy)derivative | +25,000 | $0.00 | $0 | 53,130 | Feb 25, 2026 |
| Dec 29, 2025 | Joseph A. Farnsworth director | DDisposition to issuer Options (Right to Buy)derivative | +100,000 | $0.00 | $0 | 128,599 | Feb 25, 2026 |
| Dec 29, 2025 | Robert J Brilon Chief Financial Officer | DDisposition to issuer Options (Right to Buy)derivative | +125,000 | $0.00 | $0 | 152,503 | Feb 25, 2026 |
| Feb 23, 2026 | Joseph A. Farnsworth director | AGrant or award Options (Right to Buy)derivative | +100,000 | $0.00 | $0 | 128,599 | Feb 25, 2026 |
| Feb 23, 2026 | David H. Ly Chief Executive Officer | AGrant or award Options (Right to Buy)derivative | +175,000 | $0.00 | $0 | 216,096 | Feb 25, 2026 |
| Feb 23, 2026 | Robert Gillen director | AGrant or award Options (Right to Buy)derivative | +100,000 | $0.00 | $0 | 128,599 | Feb 25, 2026 |
| Feb 23, 2026 | Alejandro Franco director | AGrant or award Options (Right to Buy)derivative | +25,000 | $0.00 | $0 | 53,130 | Feb 25, 2026 |
| Feb 23, 2026 | Robert J Brilon Chief Financial Officer | AGrant or award Options (Right to Buy)derivative | +125,000 | $0.00 | $0 | 152,503 | Feb 25, 2026 |
| Dec 29, 2025 | Joseph A. Farnsworth director | AGrant or award Options (Right to Buy)derivative | +100,000 | $0.00 | $0 | 133,625 | Dec 31, 2025 |
| Dec 29, 2025 | Alejandro Franco director | AGrant or award Options (Right to Buy)derivative | +25,000 | $0.00 | $0 | 53,130 | Dec 31, 2025 |
| Dec 29, 2025 | Robert Gillen director | AGrant or award Options (Right to Buy)derivative | +100,000 | $0.00 | $0 | 128,599 | Dec 31, 2025 |
| Dec 29, 2025 | David H. Ly Chief Executive Officer | AGrant or award Options (Right to Buy)derivative | +175,000 | $0.00 | $0 | 216,096 | Dec 31, 2025 |
| Dec 29, 2025 | Robert J Brilon Chief Financial Officer | AGrant or award Options (Right to Buy)derivative | +125,000 | $0.00 | $0 | 152,503 | Dec 31, 2025 |
| Oct 21, 2025 | Robert Gillen director | DDisposition to issuer Common Stock | -20,331 | $1.28 | $26k | 0 | Oct 23, 2025 |
| Dec 5, 2024 | Robert J Brilon Chief Financial Officer | AGrant or award Options (Right to Buy)derivative | +15,000 | $0.00 | $0 | 29,884 | Dec 9, 2024 |
| Dec 5, 2024 | Joseph A. Farnsworth director | AGrant or award Options (Right to Buy)derivative | +15,000 | $0.00 | $0 | 35,229 | Dec 9, 2024 |
| Dec 5, 2024 | Alejandro Franco director | AGrant or award Options (Right to Buy)derivative | +15,000 | $0.00 | $0 | 29,649 | Dec 9, 2024 |
| Dec 5, 2024 | Robert Gillen director | AGrant or award Options (Right to Buy)derivative | +15,000 | $0.00 | $0 | 19,320 | Dec 9, 2024 |
| Dec 5, 2024 | David H. Ly Chief Executive Officer | AGrant or award Options (Right to Buy)derivative | +15,000 | $0.00 | $0 | 41,566 | Dec 9, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Robert J BrilonChief Financial Officer
- Joseph A. Farnsworthdirector
- Alejandro Francodirector
- Robert Gillendirector
- David H. LyChief Executive Officer
Questions about IVDA
Answered from the filings on this page, as of the latest one.
Are insiders buying IVDA?
No. In the last 90 days no insider at Iveda Solutions, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade IVDA on the open market?
No open-market trade has been scored at Iveda Solutions, Inc.. The latest Form 4 on file was filed on Feb 25, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Iveda Solutions, Inc.?
5 people have filed a Form 4 at Iveda Solutions, Inc., among them Robert J Brilon (Chief Financial Officer), Joseph A. Farnsworth (director), Alejandro Franco (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.